Bristol-Myers Squibb (BMY) has shared an announcement.
Bristol Myers Squibb has shared a presentation detailing its financial and operational strategies during their first quarter earnings call for 2024, which took place on April 25. The presentation, available on the company’s website, includes a detailed comparison between non-GAAP financial measures and their GAAP equivalents, explaining the relevance of using such non-GAAP measures. While this information is not filed under the Securities Exchange Act nor intended to be used in future securities filings, it provides valuable insights into the company’s performance and strategic direction.
See more data about BMY stock on TipRanks’ Stock Analysis page.
